Thyroid cancer incidence among active duty U.S. military personnel, 1990-2004

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 11, 2011, Pages 2369-2376

  Enewold, Lindsey R ^a   Zhou, Jing ^a   Devesa, Susan S ^c   De Gonzalez, Amy Berrington ^c   Anderson, William F ^c   Zahm, Shelia H ^c   Stojadinovic, Alexander ^a,b   Peoples, George E ^a,e   Marrogi, Aizenhawar J ^a,b   Potter, John F ^a,d   McGlynn, Katherine A ^c   Zhu, Kangmin ^a,d  

^a United States Military Cancer Institute   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^e BROOKE ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARMY; ARTICLE; CANCER INCIDENCE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HEALTH CARE SYSTEM; HUMAN; MALE; NATIONAL HEALTH ORGANIZATION; PERIODIC MEDICAL EXAMINATION; PRIORITY JOURNAL; THYROID CANCER; THYROID PAPILLARY CARCINOMA; TUMOR VOLUME;

ADULT; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MILITARY PERSONNEL; SEER PROGRAM; THYROID NEOPLASMS; UNITED STATES; YOUNG ADULT;

EID: 81155132268     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-11-0596     Document Type: Article

References (48)

1. American Cancer Society. Cancer facts and figures 2011. Atlanta, GA: American Cancer Society; 2011.
2. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, et al. SEER Cancer Statistics Review, 1975-2007. Bethesda, MD: National Cancer Institute [cited 2010 Nov 15]. Available from: http:// seer.cancer.gov/csr/1975- 2007/.
3. Hall P, Adami HO. Thyroid cancer. In: Adami HO, Hunter D, Trichopoulos D, editors. Textbook of cancer epidemiology. New York: Oxford University Press; 2002. p. 504-19.
4. Burgess JR, Tucker P. Incidence trends for papillary thyroid carcinoma and their correlation with thyroid surgery and thyroid fine-needle aspirate cytology. Thyroid 2006;16:47-53. (Pubitemid 43346503)
5. Colonna M, Guizard AV, Schvartz C, Velten M, Raverdy N, Molinie F, et al. A time trend analysis of papillary and follicular cancers as a function of tumour size: a study of data from six cancer registries in France (1983-2000). Eur J Cancer 2007;43:891-900. (Pubitemid 46366691)
6. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006;295:2164-7.
7. Leenhardt L, Grosclaude P, Cherie-Challine L. Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid 2004;14:1056-60. (Pubitemid 40076130)
8. Liu S, Semenciw R, Ugnat AM, Mao Y. Increasing thyroid cancer incidence in Canada, 1970-1996: time trends and age-period-cohort effects. Br J Cancer 2001;85:1335-9. (Pubitemid 33085531)
9. Lubina A, Cohen O, Barchana M, Liphshiz I, Vered I, Sadetzki S, et al. Time trends of incidence rates of thyroid cancer in Israel: what might explain the sharp increase. Thyroid 2006;16:1033-40. (Pubitemid 46141306)
10. Smailyte G, Miseikyte-Kaubriene E, Kurtinaitis J. Increasing thyroid cancer incidence in Lithuania in 1978-2003. BMC Cancer 2006; 6:284.
11. Enewold L, Zhu K, Ron E, Marrogi AJ, Stojadinovic A, Peoples GE, et al. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev 2009;18:784-91.
12. Kent WD, Hall SF, Isotalo PA, Houlden RL, George RL, Groome PA. Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease. CMAJ 2007;177:1357-61. (Pubitemid 350207190)
13. How J, Tabah R. Explaining the increasing incidence of differentiated thyroid cancer. CMAJ 2007;177:1383-4. (Pubitemid 350207194)
14. Zhu K, Devesa SS, Wu H, Zahm SH, Jatoi I, Anderson WF, et al. Cancer incidence in the U.S. military population: comparison with rates fromthe SEER program. Cancer Epidemiol Biomarkers Prev 2009;18:1740-5.
15. Johnson CH, Peace S, Adamo P, Fritz A, Percy-Laurry A, Edwards BK. The 2007 multiple primary and histology coding rules. Bethesda, MD: Surveillance, Epidemiology and End Results Program, National Cancer Institute; 2007.
16. The North American Association of Central Cancer Registries. Report of the Automated Tumor Linkage Work Group of the ROC, October 2005 [cited 2008 Sep 15]. Available from: http://www.naaccr.org/ Standards and Registry Operations/ATLGDocs.aspx.
17. Ron E, Schneider AB. Thyroid cancer. In: Schottenfeld D, Fraumeni JF Jr, editors. Cancer epidemiology and prevention. 3rd ed. New York: Oxford University Press; 2006. p. 975-94.
18. Percy C, Van Holten V, Muir C. International classification of diseases for oncology. 2nd ed. Geneva, Switzerland: World Health Organization; 1990.
19. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al. International classification of diseases for oncology. 3rd ed. Geneva, Switzerland: World Health Organization; 2000.
20. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al. Cancer incidence in five continents. Vol. IX. IARC Scientific Publications No.: 160. Lyon, France: IARC Press; 2007 [cited 2010 Nov 15]. Available from: http://www-dep.iarc.fr/.
21. SEER research data record description cases diagnosed in 1973- 2007*. SEER research data file documentation [cited 2010 Apr]. Available from: seer.cancer.gov/manuals/TextData.FileDescription.pdf.
22. Surveillance Epidemiology and End Results (SEER) Program (www. seer.cancer.gov). SEER*Stat Database: Incidence - SEER 9 Regs Limited-Use, Nov 2007 Sub (1973-2005) 〈Katrina/Rita Population Adjustment〉 - Linked To County Attributes - Total U.S., 1969-2005 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2008, based on the November 2007 submission.
23. Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA, editors. SEER summary staging manual - 2000: codes and coding instructions. NIH Publication No.: 01-4969. Bethesda, MD: National Cancer Institute; 2001.
24. Tiwari RC, Clegg LX, Zou Z. Efficient interval estimation for age-adjusted cancer rates. Stat Methods Med Res 2006;15:547-69. (Pubitemid 46099247)
25. Peragallo MS, Urbano F, Lista F, Sarnicola G, Vecchione A. Evaluation of cancer surveillance completeness among the Italian army personnel, by capture-recapture methodology. Cancer Epidemiol 2011;35: 132-8.
26. The Royal Society. The health hazards of depleted uranium munitions. Part I. London, UK: The Royal Society; 2001 [cited 2010 Nov 22]. Available from: http://royalsociety.org/The-health-hazards-of-depleted- uranium-munitions-Part- 1-Full-Report/.
27. Boas M, Feldt-Rasmussen U, Skakkebaek NE, Main KM. Environmental chemicals and thyroid function. Eur J Endocrinol 2006;154:599-611. (Pubitemid 43810844)
28. Roger PP, Dumont JE. Thyrotropin is a potent growth factor for normal human thyroid cells in primary culture. Biochem Biophys Res Commun 1987;149:707-11. (Pubitemid 18023037)
29. Still KR, Arfsten DP, Jederberg WW, Kane LV, Larcom BJ. Estimation of the health risks associated with polychlorinated biphenyl (PCB) concentrations found onboard older U.S. Navy vessels. Appl Occup Environ Hyg 2003;18:737-58. (Pubitemid 37205728)
30. Birnbaum LS, Staskal DF. Brominated flame retardants: cause for concern? Environ Health Perspect 2004;112:9-17. (Pubitemid 38081507)
31. Herbstman JB, Sjodin A, Apelberg BJ, Witter FR, Halden RU, Patterson DG, et al. Birth delivery mode modifies the associations between prenatal polychlorinated biphenyl (PCB) and polybrominated diphenyl ether (PBDE) and neonatal thyroid hormone levels. Environ Health Perspect 2008;116:1376-82.
32. Christiansson A, Hovander L, Athanassiadis I, Jakobsson K, Bergman A. Polybrominated diphenyl ethers in aircraft cabins-a source of human exposure? Chemosphere 2008;73:1654-60.
33. Schecter A, Colacino J, Haffner D, Patel K, Opel M, Papke O. Discussion of "Polybrominated diphenyl ethers in aircraft cabins-a source of human exposure?" by Anna Christiansson et al. Chemosphere 2010;78:206-8.
34. Schecter A, Smith S, Haffner D, Colacino J, Malik N, Patel K, et al. Does flying present a threat of polybrominated diphenyl ether exposure? J Occup Environ Med 2010;52:1230-5.
35. Military Leadership Diversity Commission. From representation to inclusion; diversity leadership for the 21-st centurymilitary, final report 2011 [updated 2011; cited 2011 Aug 22]. Available from: http://mldc. whs.mil/index.php/final-report.
36. Engeland A, Tretli S, Akslen LA, Bjorge T. Body size and thyroid cancer in two million Norwegian men and women. Br J Cancer 2006;95: 366-70. (Pubitemid 44187599)
37. Guignard R, Truong T, Rougier Y, Baron-Dubourdieu D, Guenel P. Alcohol drinking, tobacco smoking, and anthropometric characteristics as risk factors for thyroid cancer: a countrywide case-control study in New Caledonia. Am J Epidemiol 2007;166:1140-9. (Pubitemid 350022755)
38. Hannibal CG, Jensen A, Sharif H, Kjaer SK. Risk of thyroid cancer after exposure to fertility drugs: results from a large Danish cohort study. Hum Reprod 2008;23:451-6. (Pubitemid 351651256)
39. Brindel P, Doyon F, Rachedi F, Boissin JL, Sebbag J, Shan L, et al. Menstrual and reproductive factors in the risk of differentiated thyroid carcinoma in native women in French Polynesia: a population-based case-control study. Am J Epidemiol 2008;167:219-29.
40. Negri E, Dal Maso L, Ron E, La Vecchia C, Mark SD, Preston-Martin S, et al. A pooled analysis of case-control studies of thyroid cancer. II. Menstrual and reproductive factors. Cancer Causes Control 1999;10: 143-55. (Pubitemid 29161106)
41. Nasseri K. Thyroid cancer in the Middle Eastern population of California. Cancer Causes Control 2008;19:1183-91.
42. Rezzonico J, Rezzonico M, Pusiol E, Pitoia F, Niepomniszcze H. Introducing the thyroid gland as another victim of the insulin resistance syndrome. Thyroid 2008;18:461-4. (Pubitemid 351519543)
43. Thompson IM, Optenberg S, Byers R, Dove M. Increased incidence of testicular cancer in active duty members of the Department of Defense. Urology 1999;53:806-7. (Pubitemid 29163050)
44. Yamane GK. Cancer incidence in the U.S. Air Force: 1989-2002. Aviat Space Environ Med 2006;77:789-94. (Pubitemid 44232236)
45. Amis ES Jr, Butler PF, Applegate KE, Birnbaum SB, Brateman LF, Hevezi JM, et al. American College of Radiology white paper on radiation dose in medicine. J Am Coll Radiol 2007;4:272-84. (Pubitemid 46671375)
46. Mettler FA Jr, Thomadsen BR, Bhargavan M, Gilley DB, Gray JE, Lipoti JA, et al. Medical radiation exposure in the U.S. in 2006: preliminary results. Health Phys 2008;95:502-7.
47. Bertakis KD, Azari R, Helms LJ, Callahan EJ, Robbins JA. Gender differences in the utilization of health care services. J Fam Pract 2000; 49:147-52.
48. Wang C, Carpo LM. The epidemiology of thyroid disease and the implications for screening. Endocrinol Metab Clin North Am 1997;26: 189-218. (Pubitemid 27123901)